1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CALGB 80802 (Alliance): Impact of sorafenib with and without doxorubicin on hepatitis C infection in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Kumthekar, P.; Jacobson, S.; El Dika, I.; Yaqubie, A.; Lopez, J.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: A randomized controlled trial
    Journal Article

    Mao, H.; Jin, M.; Xie, L.; Mao, N.; Shen, X.; Chen, J.; Chen, X.; Mao, J. J.; Shen, X.
    Breast Cancer Research (2024)

    Fulltext@MSK | Save
  • Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components
    Journal Article

    Wheeler, A. P.; Snyder, E. L.; Refaai, M.; Cohn, C. S.; Poisson, J.; Fontaine, M.; Sehl, M.; Nooka, A. K.; Uhl, L.; Spinella, P. C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nocebo expectations rather than placebo expectations affect topical pain relief: A randomized clinical trial
    Journal Article

    Yang, M.; Li, Q. S.; Baser, R. E.; Li, X.; Hou, J.; Mao, J. J.
    Biomedicine and Pharmacotherapy (2024)

    Fulltext@MSK | Save
  • Pegargiminase plus first-line chemotherapy in patients with nonepithelioid pleural mesothelioma: The ATOMIC-Meso randomized clinical trial
    Journal Article

    Szlosarek, P. W.; Creelan, B. C.; Sarkodie, T.; Nolan, L.; Taylor, P.; Olevsky, O.; Grosso, F.; Cortinovis, D.; Chitnis, M.; Roy, A.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Evaluating a physician audit and feedback intervention to increase clinical trial enrollment in radiation oncology in a multisite tertiary cancer center: A randomized study
    Journal Article

    Verdini, N. P.; Gelblum, D. Y.; Vertosick, E. A.; Ostroff, J. S.; Vickers, A. J.; Gomez, D. R.; Gillespie, E. F.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial
    Journal Article

    Brazauskas, R.; Flynn, K.; Krishnan, A.; Landau, H.; Giralt, S.; Pasquini, M. C.; Stadtmauer, E. A.; D'Souza, A.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients
    Journal Article

    Hay, J. L.; Wu, Y.; Schofield, E.; Kaphingst, K.; Sussman, A. L.; Guest, D. D.; Hunley, K.; Li, Y.; Buller, D.; Berwick, M.
    Psycho-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluating the psychometric properties of the Hispanic Stress Inventory-2 Simplified version among a diverse sample of Latinos who smoke
    Journal Article

    Hernández-Torres, R.; Cartujano-Barrera, F.; Arana-Chicas, E.; Chávez-Iñiguez, A.; Dontu, V.; Gao, S.; Cai, X.; Castro-Figueroa, E.; Ossip, D. J.; Cupertino, A. P.
    PLoS ONE (2024)

    Fulltext@MSK | Save